Long-Term Consequences of Endocardial Leads Present in Cardiovascular System by Barbara Małecka
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Long-Term Consequences of 
Endocardial Leads Present in 
Cardiovascular System  
Barbara Małecka 
Department of Electrocardiology, Institute of Cardiology, 
Jagiellonian University Collegium Medicum, 
John Paul II Hospital in Krakow, Krakow 
Poland 
 
Acknowledgements to Andrzej Ząbek for his authorship of 
Figures Section as well as Multimedia Section. 
1. Introduction 
Endocardial leads for permanent heart stimulation and cardioverter/defibrillator ones have 
been implanted for 52 and 20 years, respectively. From the very beginning of the age of 
heart stimulation with the use of endocardial leads, there have been considered reactions of 
coagulation and immunological systems as well as the changes to the endocardium and the 
blood vessels in response to the leads in them. In the technological process the leads are 
covered by external insulation made by polymer materials with bio-compatible properties, 
that is ones not inducing side effects. Mass implantation of systems for permanent 
stimulation and implantable cardioverter/defibrillator (ICD) could take place only at the 
age of developed electronics. Recently we have celebrated the 50th anniversary of permanent 
heart stimulation. Since that time the number of patients with cardio implants in the right 
heart have proliferated and also their life expectancy have become substantially prolonged. 
Over a 50 year-old history of permanent heart stimulation presents a number of arguments 
to show that ideas of full bio-compatibility of polymer covered leads (usually silicone and 
polyurethane) were only a wishful thinking. Patients with pacemaker (PM) and ICD 
systems tend to live longer and possess more, sometimes up to 20 or 30 years old leads in 
their hearts, which causes a variety of complications. 
2. Cardiovascular system response to the leads 
2.1 Vegetations and a need for broadening indications for anticoagulant treatment in 
patients with endocardial leads 
Nowadays, an easy access to the echocardiography and especially transesophageal 
echocardiography (TEE), allows to reveal in the hearts of some patients (5-14%) masses of 
various consistency, shape and diameter, associated with the leads or the surrounding 
endocardium, called vegetations (Lo et al., 2006). The term ‘vegetation’ is a histological term 
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and means “a shapeless mass of platelets or fibre, which can contain microorganisms and 
inflammatory cells”. 
In the echocardiography there can be observed vegetations in shape of loose, moving whips 
or spherical, compact ones. The former occur in connection with the leads coming across the 
cavity lumen and follow the flow of blood filling or emptying the heart. The latter, spherical, 
compact vegetations are sometimes connected with the endocardium surrounding the leads 
like the stalk. It follows the Byrd division (Byrd, 2007), according to which the right heart 
vegetations divide into: 
1. less compact, long, greatly movable (clot) and 
2. more compact, spherical, sometimes having a stalk and less movable (thrombus).  
TEE examinations repeated several times in the same patients revealed that vegetations in 
the right heart are not permanent phenomena, but tend to appear and disappear in the same 
place; some of them undergo lysis, and other move to the pulmonary bed. According to the 
above, the existence of vegetations and accounting from it danger of pulmonary embolism 
needs further detailed studies. Nowadays, there are only case reports of a pulmonary 
embolism on removal of an infected stimulation system, or an embolism caused by a 
missing part of a broken lead.  
Theoretically there is a number of reasons for pulmonary embolism after an implantation of 
a PM/ICD system. They are as follows: 
1. Stimulation system is a foreign body and stimulates clotting. 
2. Anti-thrombotic drugs are stopped for the time of the procedure. 
3. In the lead dependent infective endocarditis (LDIE)  infected vegetations move to the 
pulmonary bed.  
Yet, the guidelines for the prophylactic anticoagulant drug administration do not list 
endocardial leads as one of the threats. That suggests the need for broadening the 
indications for anticoagulant treatment in patients with multi-lead PM/ICD systems, 
especially in patients with  incidentally diagnosed asymptomatic vegetations. Until now, the 
existence of a vegetation in the left heart could be revealed only after  the diagnosis or the 
suspection of endocarditis.  
A vegetation in the right heart with multiple leads constitutes an element of the diagnosis of 
the endocarditis only in presence of other infective clinical or laboratory symptoms. Finally, 
the importance of an isolated vegetation with no inflammatory symptoms, is still an 
unknown. Does the vegetation lead to the infection or result from it?  
A conception of the thrombotic endocarditis casts some light on the above doubt. The 
damage of the endothelium leads to the creation of the microscopic thrombus composed of 
platelets and fiber and much more exposed to bacterial colonization than healthy 
endothelium. Two mechanisms take part in the primary creation of the thrombus: damaged 
endothelium and hyper-coagulability. Hemodynamic situations increasing the turbulence of 
the blood flow lead to endothelium lesions. A logical conclusion, thus, is that the leads, 
moving in the blood that continuously flows, can stimulate clotting along their surface, and 
the thrombi, created in that way, can become infected. An additional stimulus for clotting 
can be rubbing of the endocardium with the leads moving around or abrasion of the 
external lead insulation with exposure of its internal metal wire.   
2.2 Endothelialization processes 
Observations made by cardio-surgeons during the lead removal procedures with the use of 
cardio-pulmonary bypass present the effects of the productive changes connected with the 
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existence of the leads in the heart cavities. One of those changes is the endothelialization, 
that is process of  covering the leads with smooth endothelium and  attaching them firmly to 
the walls of the cardiovascular system. Thus, the lead, which is a foreign body, becomes 
separated from the blood flow which makes contact with the bacteria during periods of 
bacteremia impossible. Endothialization takes place in the regions where the lead is 
relatively stable regarding the walls of the blood vessel or the heart and adheres well to their 
endothelium (Esposito et al., 2002).  
Can we assume that the process of endothalialization has been already well known, 
altogether with all its consequences during removal procedures? It is well known though, 
that it doesn’t cover the whole length of the lead. The extent of the lead closed in the tunnel 
created by the endothelium depends most probably on the polymer used for the lead’s 
insulation, as well as on the spatial localization of the leads in regards to the walls of the 
blood vessels and the heart cavities. The most privileged places of in growing of the leads to 
the walls of the blood vessels and the heart, observed during percutaneous and cardio-
surgical procedures of lead extraction, constitute a marked map of technical difficulties 
during these procedures. The strongest, most durable and therefore most difficult to cut off 
adhesions occur at the junction of the vena innomina and vena cava superior, in the upper 
part of the right atrium, in the vicinity of the tricuspid valve as well as in the very right 
auricle (Byrd, 2007). In these places there is an increased risk of perforation and bleeding 
during lead removal procedures.  
3. Lead dependent infective endocarditis 
Infective endocarditis (IE) was first described over a 100 years ago. Since late 20th century 
New Duke’s criteria, broadened by echocardiographic examination results, have been 
introduced.  Textbook descriptions of this disease mention, insufficiently though, the 
difference in the course of IE regarding the left and the right heart. There are significant 
differences in etio-pathogenetic factor, clinical course of disease and prophylactic 
indications. The descriptions of the disease and the experience gained after observing the 
course of IE were obtained on the basis of observation of infected left heart valves and their 
prostheses. Such observations were possible due to the development of cardio-surgical 
methods of valve defect corrections since mid 20th century and because of  an increasing 
popularity of left heart implants. IE proceeds with bacteremia of the systemic circulation 
and severe infection symptoms such as fever (80%), weakness (25-40%), joint and muscle 
pain (15-30%), appetite and weight loss (30%) accompanied by characteristic skin color (café 
au lait). The object examination revealed symptoms of heart failure, valve damage, and the 
effects of complications caused by embolism in the systemic circulation (spleen, skin, 
kidneys, brain, extremities). There were also noted spectacular but rare  vascular symptoms 
(5-15%): skin extravasations, the effect of a splinter driven into the nail, Ossler’s nodules, 
Roth’s retinal spots and a Janeway symptom (Habib et al., 2009). The second part of the 20th 
century brought the news about the bacterial endocarditis of the right heart. The problem 
was noticed in drug addicts, and as a iatrogenic complication in patients with catheters in 
their right heart cavities as well as in patients under long-term hospitalization (Baddour et 
al., 2003). In the recent years infective complication of long term existence of endocardial 
leads in the blood vessels and heart cavities have been increasingly observed. Possibility of 
the right heart infective endocarditis was implicated in patients with permanent PM/ICD 
systems (Klug et al., 1997). A certain delay in appreciation of the right heart IE in patients 
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with PM/ICD can be well understood in the face of a later development of the 
contemporary electrotherapy compared to the cardio-surgical corrections of heart valve 
defects.   
Risk factors of infections connected with PM/ICD systems are as follows: fever prior to the 
implantation procedure, temporary stimulation, repeated procedure e.i. exchange /revision 
of a system, early repairs and lack of antibiotic prophylaxis (Klug et al., 2007). 
 The etiology of the LDIE is predominantly bacterial (90%) and the pathogens responsible 
are mainly Staphylococci (Aureus and Epidermidis), Streptococci, Enterococci, 
Pneumococci, Gonococci, group HACEK gram- bacteria, mycobacterium and sporadically 
fungi (Candida albicans, Aspergillus sp., Histoplasma capsulatum) and other (chlamydia, 
rickettsias,  mycoplasmus).  
From the pathomorphologic point of view LDIE is characterized by vegetations visible in 
the echocardiography, especially in TEE.  Vegetations can, in a natural way, migrate to the 
pulmonary circulation and consequently, lead to pulmonary embolism.  
Classic symptoms of LDIE are:  
1. Local  PM/ICD pocket infection (of different frequency). 
2. Pulmonary symptoms: cough and pleural chest pain, dyspnoea, advanced symptoms of 
pneumonia, atypical lung changes in the x-ray chest scan suggesting pulmonary 
embolism by infected vegetations (26-41%). 
3. Severe inflammatory state of the whole organism: persistent fever (80%), shivers (75%), 
weakness, feeling tired (75%), loss of appetite (36%), sweats (32%), café au lait skin color 
(relatively late). 
4. Laboratory IE indicators such as blood culture tests results (about 70%), anaemia (66%), 
leukocytosis (59), increased ESR, CRP (59%), erythrocyturia and albuminuria are rare 
symptoms of the disease (Greenspon et al., 2008; Massour et al., 2007; Sohail et al., 
2008).  
This disease entity lacks the symptoms typical for infected vegetations in the left heart 
(small Duke’s symptoms). Vegetations and embolisms do exist but in the pulmonary 
circulation. For the fact that several symptoms may not reveal, the disease is usually 
diagnosed very late, and sometimes left undiagnosed until patient’s death. Patients with 
LDIE happen to be referred for pulmonary, medical or even oncologic diagnostic 
investigations due to atypical and ambiguous changes seen in their chest x-ray scans. Those 
changes usually subside after antibiotic treatment, with no permanent recovery, though. The 
disappearance of a vegetation from the echocardiography picture is not synonymous with 
recovery if the leads are left in heart cavities. In case of repetitive infections it is crucial to 
consider LDIE in a patient with a cardio-implant in the form of a lead in the right heart, with 
possible vegetations on it [Figure 1].  
4. Multiple endocardial leads, abandoned, migrated – a growing problem in 
electrotherapy 
4.1 Multiple leads 
It was assumed that the implanted lead is inexchangable and should be sufficient for the 
patient's whole life. Thanks to the extended life expectancy of patients with PM/ICDs there 
has appeared an opportunity  to observe endocardial  leads staying long in the human body. 
However, time has verified the above assumption negatively. A logical conclusion seems to 
be, that the risk of breakage, abrasion or migration ('dropping in') of the inactive lead 
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Fig. 1. Vegetations in the course of LDIE visualized by different techniques. 
A. TTE: modified 4 – cavity projection. The vegetation connected with the lead in the right ventricle 
(crosses); the lead (arrow). 
B. TEE: 2 – cavity projection. The vegetation connected with the lead in the right atrium (crosses); the 
lead (arrow). 
C. C,D,E. Figures presented thanks to courtesy of dr E. Czekajska – Chehab; Lublin Medical   
University. 
D. C,D. MSCT (Multi Sliced Computer Tomography) of the thorax. MIP (maximum intensity 
projection) reconstructions. The vegetation connected with the lead in the right atrium (arrow). 
E. 3D reconstruction of the vegetation in the patient from figure C&D. 
F. Intraoperative picture of the endocardial lead removal procedure with cardio – pulmonary bypass. 
Visible vegetation connected with the lead.  
G. Magnified vegetation from fig. F.   
H. Vegetation connected with the lead under the optic microscope. 
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increases every year further from the implantation. All inactive leads need to be substituted 
with new ones, older systems can be upgraded and PM systems changed into ICD systems, 
which results in multiple lead existence in cardiovascular system [Figure 2].  
 
 
Fig. 2. Multiple leads in chest x–ray scan.  
A. Postero-anterior projection in a patient with PM – CRT (Cardiac Resynchronization 
Therapy).Visible 4 leads: One of the atrial leads broken and migrated to the left subclavian vein 
(arrow 1); Second atrial lead implanted from the right subclavian vein and lead to the left PM 
pocket due to the obstruction of the left subclavian vein (arrow 2); Remaining leads: right 
ventricular  (arrow 3) and left ventricular (arrow 4).  
B. Postero – anterior projection in the patient with ICD. Visible 4 leads: one of the atrial leads broken 
and migrated to the left subclavian vein (arrows 1), the other atrial lead is active (arrow 2), 
abandoned PM lead for right ventricle apical stimulation (arrow 3), ICD lead implanted to the 
right ventricle outlet track (arrow 4).  
C. Postero – anterior projection in the patient with a single lead  atrio – ventricular PM system on the 
right side. Additionally visible two abandoned leads implanted from the left side. 
D. Lateral projection in the patient with from fig. C.  
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4.2 Vascular obstruction 
The existence of leads in the veins causes thrombosis and vascular obstruction in high 
percentage of patients (Rozmus et al., 2005) [Figure 3]. This lead dependent complication of 
a permanent stimulation can sometimes significantly lower the quality of life of a patient  
 
 
Fig. 3. Vascular obstruction in the presence of the endocardial leads visualized by different 
techniques 
A. Chest X-ray scan: postero-anterior projection.  Intraoperative venography of the left vein flow in a 
patient with PM – CRT. Visible lateral circulation as a result of the obstruction of the left 
subclavian vein. 
B. MSCT in a patient with PM. Visible lateral circulation as a result of obstruction of the left 
subclavian vein. 
C. MSCT in the patient with PM on the right side and abandoned leads on the left side. Visible 
obstruction of the innominate vein and current lateral circulation as well as narrowing of the right 
subclavian vein lumen. 
D. MSCT in the patient with PM. Visible lateral circulation as a result of obstruction of the left 
subclavian vein. 
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(edema of an upper limb, face, in extreme cases a typical vena cava syndrome) but, what is 
even more important, it makes an implantation of the lead  for the planned system upgrade 
impossible. In such situations it is possible to regain vein lumen by removal of one of the 
leads, since the lead in the obstructed vein constitutes “the access door” to the heart. There 
is also a possibility to treat the vascular obstruction by plastic surgery (with the use of the 
stent or without). The analysis of long-term efficiency of plastic surgery of great veins with 
endocardial leads present in them has not been made so far. 
4.3 Abandoned leads resulting in multiple lead existence in cardio-vascular system 
What do we know about the potential risk of abandoning inactive leads in the heart cavities? 
From the clinical practice it is known that increased number of the leads in the cardio-
vascular system causes negative effects to the veins, to the function of the tricuspid valve 
and PM/ICD pocket. Multiple leads in the heart increase the risk of lead external insulation 
abrasions, for the fact that the leads continuously rub against one another with frequency of 
the heart rhythm. External insulations of the leads can, for that reason, undergo mechanical 
abrasion, exposing their metal wire, and generate thrombosis and secondary pulmonary 
embolism in those places. In this way a place for 'anchorage' of the dangerous LDIE is 
created. Coils of the leads' proximal part lying in the pocket enlarge its volume and so 
increase the risk of the decubitus of the skin which covers the PM/ICD pocket. Apart from 
that there is a high risk of migration of the proximal end of the abandoned lead  inside the 
vascular system, which can trigger a number of further complications (Bohm et al., 2001). 
Even though Heart Rhythm Society (HRS) 2009 guidelines present indications for lead 
removal in particular cases, we should focus not on asking whether to remove an inactive 
lead but whether if and when we are allowed to leave it in the cardiovascular system 
(Wilkoff et al., 2009).  
4.4 Migrating leads 
An abandoned, cut short and not sufficiently fixed lead creates the risk of migration to the 
cardiovascular system. Active endocardial leads may also migrate to the cardiovascular 
system after being damaged up to the total break-up. This may occur as a result of the crush 
syndrome in case of unfavorable position of the lead and the clavicle (Magney et al., 1993). 
There is also a risk of lead’s break-up at the site of ligature tightening on the lead in the 
pacemaker pocket.  
The migration of the lead’s proximal end to the subclavian, brachio-cephalic vein or vena 
cava superior creates loops, which in turn move through the tricuspid valve to the right 
ventricle provoking valve dysfunction and ventricular arrhythmias [Figure 4].  
Sometimes the free end of the lead drops in the right heart cavities or pulmonary artery 
causing pulmonary embolism.  
Practically, every lead, the free end of which is dropped in the cardiovascular system becomes 
a potential source of the consequences mentioned above and is class 1 (lead with ending in CVS, 
which may pose an immediate threat to the patient if left in place, life threatening arrhythmias secondary 
to retained lead or lead fragment) or class 2b (lead which may pose a potential future threat to the 
patient if left in place) according to the latest guidelines of the HRS (Wilkoff et al., 2009).  
There are no descriptions of percutaneous lead removal procedures with free ends migrated 
to the cardiovascular system, based on a larger population of patients with such a problem, 
except single or a few patients case reports. 
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Fig. 4. The lead dropped in and coiled in the heart in the X-ray chest scan in a patient with PM.  
A. Postero-anterior projection. Dropped in lead (arrow 1); Active lead (arrow 2) 
B. Lateral projection. Labeling leads in A.  
 
 
Fig. 5. Inside-heart abrasions of leads in a patient with PM. 
A. Chest X-ray scan: postero-anterior projection. Atrio-ventricular PM system with 2 leads. Visible 
mutual contact of two leads at the bottom of the right atrium (arrow). 
B. Intraoperative picture with the removed atrial lead in a patient from figure A: visible abrasion of 
the lead’s silicone insulation (arrow). 
C. Optic microscope picture: visible abrasion of the silicone external insulation. 
4.5 Mechanical damage of the leads 
Studies on the subject have given a number of information about mechanical damage to the 
endocardial leads resulting from their construction imperfections, implantation procedures 
as well as human anatomy. A phenomenon of lead abrasion between the clavicle and the 
first rib in the 'crush syndrome' mechanism as well as external insulation abrasions of the 
leads coiled in the PM/ICD pocket caused by rubbing against the system can are well 
known phenomena.  
Inside-heart abrasions of silicone lead insulations have also been discovered (Kutarski et al., 
2009; Kołodzińska et al., 2010) [Figure 5]. This phenomenon is probably a significant factor 
in creation and/or generation of vegetations, thrombi and LDIE. It has been proved, that in 
the group of patients with abraded leads, patients with several leads are predominant. Thus, 
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it can be concluded that there is a certain relation between the number of leads in the heart 
and incidents of their abrasion. The abrasions have been observed more often in the older 
stimulation systems: after at least 2 years in the CRT systems and four years in DDD 
systems. Such findings mean that probability of leads' abrasions is similar in every multi-
lead system. A condition under which an abrasion occurs is a specific spacial localization of 
multiple leads in the right heart. It predisposes bumping or/and rubbing of the leads 
against one another, with the frequency of the heart beat. The phenomenon of lead abrasion 
occurs only in the right heart cavities, especially in the atrium and sporadically in the 
ventricle. Leads' abrasions are possible to occur only  when the leads move in opposite 
directions to one another, with different spatial configurations: 
a. a too long atrial lead loop with its distal end in the auricle, which continously rubs 
against the atrial part of the ventricular lead, 
b. a lead running through the coronary sinus outlet  crosses right above the tricuspid 
valve with the ventricular lead running towards the right ventricle, 
c. two lead loops cross each other  in the right ventricle.   
The discovery of  endocardial lead abrasions puts the durability of leads for permanent 
heart stimulation  as well as current techniques of their  implantation  in a new light. 
Abrasions in the atrio-ventricular systems in which the atrial lead was implanted in the sites 
where it couldn't move was not observed. This applies to Bachman's bunch (roof of the right 
atrium), as well as to the anterior part of the atrial septum. 
Prospective, randomized research of lead abrasions in people are not possible for ethic 
reasons.  They would have to assume planned lead removals for solely cognitive reasons, 
with no  therapeutic indications for the procedure carrying nearly 1% risk of death. The 
process of abrasion takes too long to observe it in studies on animals. Endocardial lead 
external insulation abrasions  have been discovered in the leads covered with silicone, 
which does not exclude the possibility of  abrasions in the leads covered with polyurethane 
or other polymer materials. 
4.6 Choice of the lead model 
Considering to use a lead for heart stimulation  we often tend to forget about possible late, 
even very far away complications. A lead which is too long for the patient's heart needs to 
be looped in the pocket several times. In this way a skin decubitus or abrasion of the lead's 
insulation inside the stimulator pocket is created. We pay too much attention to stimulation 
conditions ('low-treshold) and leads' dislocation percentage (non-dislocating leads) and 
much too little to the ways of removing the leads years later. Deffibrillation leads cause most 
technical problems. Most adhesions (bridges) of the connective tissue are formed in the vena 
innomina and vena cava superior, and the strongest ones (often obstructing the vein's 
lumen) are formed on the proximal coil.  However, removability constitutes one of the most 
crucial features of the lead.  
5. Lead removal procedures  
Percutaneous removal of endocardial leads is the most difficult electrotherapy procedure 
carrying 1% risk of intraoperative death. It is still an alternative for cardio-surgical 
procedures, which are more strenuous for the patients and carry 10 times as high percentage 
of death (Camboni et al., 2008). The later from the implantation procedure the more 
technical difficulties are encounted during removal  with significant increase of its risk. The 
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growth of the connective tissue around the leads is a well known factor  which  makes the 
procedures of percutaneous lead removal more difficult.  It increases the risk of great vein 
and the right heart ruptures with fatal bleeding.  
Technical details of every lead removal  can contain elements going beyond a stereotypical 
procedure. Individual anatomical conditions or specific leads’ configuration force the 
operators to create unique, original modifications.  
A percutaneous lead removal in presence of large (over 2cm in diameter) vegetations with 
protection of the pulmonary bed against the  pulmonary embolism becomes the challenge of 
the oncoming times (Małecka el al., 2010). The literature describing lead removal with no 
laser or radiofrequency back up  presents Bongiorni’s technique, which uses rotation-cutting 
forces with/and change of the leads into free floating ones (Bongiorni et al. 2008).  
5.1 Removal of leads with proximal ends accessible in the PM/ICD pockets with the 
use of rotation-cutting forces 
Extraction  of the leads is initiated by removing the stimulator from the pocket. In presence 
of an infection, a smear of the pocket discharge and/or blood culture test of the tissue is 
required. Next, the leads are let off the ligatures in the pocket and the tunnel leading to the 
large vessel ( usually the subclavian vein). Inside the leads ‘anchoring’ or ‘ non-anchoring’  
leaders are introduced. The choice of the type of the leader  mostly depends on the condition 
of the lead’s lumen. Our own experience shows that it is usually impossible to use the 
‘anchoring’ leader, which is supposed to carry the pulling forces onto the distal end (of the 
lead) or the whole lead. It is connected with the advanced age of the removed leads and 
resulting from it destruction of their structure, a common phenomenon of a ‘crush 
syndrome” in Polish patients ( having leads implanted from the unfavourable peristernal 
puncture of the subclavian vein or working physically hard despite implantation of the 
endocardial leads). 
Not infrequently it is associated with failed attempts to remove the stimulation system  in 
patients’ home centers.  In the situation when the lead’s lumen is distorted and the leader 
cannot reach the very end of the lead, it seems to be the best solution to stiffen as long 
section of the lead as possible with a ‘non-anchoring’ metal leader. 
At a later stage of the procedure the proximal lead ends are secured with long, strong, 
ligatures, which, at the same time, tighten the lead during the process of its being freed from 
the connective tissue bridges. Those strong ligatures are tied to the leads in such a way to 
crush and connect  all layers of the lead, together with the metal leader inside. The ligatures 
are tied around the lead in a way to prevent leads’ diameter  from considerable growth , as 
well as from cutting it. In case of an ‘anchoring’ leader being used, the ligatures are 
additional elements of the traction system.  
Steel preparation sheaths of possibly smallest diameter are used to overcome the resistance 
of tissues in the subclavian region. Having gained the access to the subclavian vein the steel 
sheaths are substituted with a pair of teflon or polypropylene sheaths, so called Byrd 
dilators, which act in a telescopic way. The experience shows that the operator should have 
all dilator sizes ( according to colors) and two standard lengths 33/38 and 41/46 cm at hand. 
In case of encountering a significant resistance (usually in vena cava superior) 
polypropylene dilators are exchanged for the other ones, usually of a bigger diameter (blue, 
yellow, green, white, and orange). Recommendations of the company can be confirmed that 
unipolar leads can usually be removed with the use of blue and yellow dilators, bipolar ones 
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with yellow or green sheaths, and ICD leads with green or white and sporadically orange 
dilators.  
The lead removal procedure builds upon slow (millimeter after millimeter!) freeing  the lead 
from connective tissue bridges, vegetations, endothelialization tunnels with the use of 
rotation of a catheter cut diagonally, that is with the use of rotation-cutting forces. At this 
stage of the procedure and maneuvers associated with it, it is essential for the other operator 
to keep a proper tension of the lead. The first operator is at the same time highly occupied 
with proper position ( i.e. lengthwise to the  wall  the blood vessel and later to the heart 
cavities) of the dilators during maneuvers, which are mainly rotation movements exerting 
delicate pressure on the lead. A single catheter meets the increased friction resistance  the 
deeper it goes into the vascular system, whereas the technique of a ‘catheter in a catheter’ 
allows to move (rotate) dilators with much less resistance from the tissues and a lower risk 
of breaking or wrenching the dilator off. 
From the moment of reaching the ingrown distal end of the lead with the dilators, the 
phenomenon of a counter traction is put into use, i.e. supporting  the tissue around the 
lead’s end and preventing it from moving along with the lead which is being freed and 
pulled outside. 
At all stages of the procedure a careful observation of patient’s heart rhythm and vital signs 
is necessary.  
5.2 Removal of dropped-in leads 
Such procedures usually do not proceed in a typical way. Most frequently they are a 
demonstration of operators skills in using various types of anchoring and pulling catheters, 
and   ad hoc modifications of techniques offered by the companies. 
In order to remove a lead without its end accessible in the pocket, a Byrd workstation is 
introduced into one of the femoral veins. The catheters to catch the lead are introduced via 
the workstation. The choice of the catheter depends on the experience and liking of an 
operator and also on the spatial situation. The ‘pigtail’ catheter is considered to be the one of 
the first choice.  
The next popular catheter is the Dotter’s basket.’ Needle snare eye’, though,  has proved to 
be of little use in many of the procedures performed so far. It is probably connected with 
presence of multiple leads in the heart and with the situation when the coiled lead being 
removed is only one of the leads in the heart. Having grasped the floating end of the lead, it 
is moved outside the femoral vein. Then the traction used in the sheath that creates counter 
traction  should be sufficient, according to the equipment producers, for pulling the lead 
from the adhesion in the heart. Own experience shows that the situation is much more 
complicated. Usually, the lead being removed has some more adhesions to the heart or to 
another lead. In such cases cutting properties of polypropylene Byrd dilators or other 
diagonally cut, sharpened catheters can be successfully used.   
5.3 Potential complications and safety precautions during percutaneous lead removal 
procedures 
Contrary to the general opinion, the possibility to damage the wall of the right ventricle 
does not constitute the greatest danger caused by releasing the leads from the connective 
tissue bridges or the endothelialization tunnels. During percutaneous removals of the old 
and strongly ingrown and immobilized leads we are mostly concerned with the following: 
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- Damage of the subclavian vein / vena innomina / vena cava superior: the surgical 
intervention is most difficult due to the difficult access, 
- Damage of the subclavian artery, creation of V –A fistula to a lesser extent, 
- Massive pulmonary embolism by the torn off large vegetation, 
- Damage of the coronary sinus: applies to removals of left - atrial leads and left - 
ventricular leads. 
During the procedures we are much less concerned with their consequences in the form of 
damage of the right atrium, right  ventricle or tricuspid valve. In such situations the cardio-
surgical intervention is not always necessary, and technically easier due to the easy access in 
case the intervention is indispensable. Massive bleeding to the mediastinum or pleural 
cavity or massive pulmonary embolism are the most dangerous complications and can lead 
to death before the delayed cardio-surgical intervention. Thus, the back up of the cardio-
surgical and anaesthesiological team ready to act at any moment is essential.   
In the presented technique of percutaneous lead removal the key role is the experience of 
the main operator. Independently from the degree of their training and having in mind the 
risk of potential complications, it is necessary to backup every procedure of percutaneous 
lead removal by an experienced cardio-surgeon, prepared for a quick joining of the great 
vessels or removing of the embolic material from the pulmonary trunk. Safety of such 
procedures is also increased by the angio-surgeon being available and, if possible, an 
experienced operative radiologist. It is also desirable to perform the procedure in a cardio-
surgical operation room with a high class X-ray apparatus. 
6. Spontaneous delayed heart perforation caused by endocardial lead 
Incidence of the delayed heart perforation is proved to be low (at 0,1-0,8% for pacemakers 
implantation and 0,6-5,2% in ICDs) (Khan et al., 2005), probably due to “self-sealing” 
properties of the ventricle wall: fibrosis, muscle contraction or by the lead itself.  
Suspected risk factors for heart perforation are as follows: 
• temporary stimulation, 
• atrial stimulation, 
• stimulation with active fixation system, 
• defibrillator leads, with double spirals (more wires, stiffer), 
• when excessive length during implantation is left, 
• small diameter (increased force per unit area), 
• the so-called high resistance (small tip surface). 
The literature presents reports about higher perforation rate in case of a certain lead types 
(eg. Riata ST Jude Medical leads), which might indicate that some constructive elements of 
the leads may predispose heart perforation. It is known that this condition occurs more 
often in localizations of the distal end of the lead such as right ventricular apex.  
Apart from the two above conditions the state of the heart may also favor perforation.  
Anticoagulation and steroid therapy, low body mass index, female gender and incidental 
chest trauma may trigger perforation.   
Delayed right ventricle perforation may have several clinical symptoms:  
• chest pain, 
• dyspnea, 
• syncope (due to improper stimulation or its complete failure), 
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• inadequate ICD shocks, 
• muscle or diaphragm stimulation, 
• abdominal pain (due to diaphragm stimulation or lead migration to the peritoneal 
cavity), 
• hiccup (as a symptom of the phrenic nerve stimulation), 
• mammary hematoma, 
• consequences of the diaphragm, lung, chest wall perforation, 
• pleural or pericardial effusion, rarely demanding drainage. 
The most common symptom is the electric dysfunction: sensing, pacing and impedance. 
Sometimes perforation occurs also with normal electrophysiological parameters. Thus, it can 
be concluded, that improper function may indicate perforation but its normal function does 
not exclude it.   
Perforation diagnosis can be confirmed by visualization techniques:  
chest X-ray, transthoracic (TTE) or transoesophageal (TEE) echocardiography and computed 
tomography [Figure 6]. X-ray is efficient in revealing distal lead end migrations outside the 
heart and assessing pleural effusion.  
Echocardiography can present more discreet changes in lead migration. It is also a good 
technique for assessing pericardial effusion.  The golden mean, however, stays computed 
tomography (CT).  
 
 
Fig. 6. Delayed heart perforation by endocardial lead visualised by different techniques.  
A. Transthoracic echocardiography (TTE). 
B. MSCT in the same patient. MIP projection. The lead  is perforating the wall of the right ventricle 
(arrow).  
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